NCT06378853Completed
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients Based on Body Compositions Measured by 3D CT Scan and Hematological Indicators
Source: ClinicalTrials.gov · Last updated 23 Apr 2024
Brief summary (registry, in English)
By evaluating the nutritional status of patients with pancreatic ductal adenocarcinoma (PDAC) admitted to Jinling Hospital, collecting relevant clinical data. we aim to conduct correlation analysis with patient clinical information, such as survival time, hospitalization time, nutritional status, hematological indicators, etc., in order to reveal the prognostic factors for overall survival and postoperative complications of PDAC patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 548 (actual)
- First submitted
- 18 Apr 2024
- Start date
- 1 Jan 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Jinling Hospital, China
- Diseases
- Pancreatic cancer
- NCT number
- NCT06378853
What you commit to
- Study type: Observational
- Participants enrolled: 548
- From 1 Jan 2019 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\) Suffering from chronic or acute diseases related to malnutrition: chronic heart failure, cirrhosis, chronic kidney disease and infection, cognitive impairment, dysphagia or gastrointestinal obstruction, etc; 2) Using excessive doses of systemic glucocorticoids within 4 weeks prior to enrollment;
Who the study is looking for
- All eligible patients diagnosed with PDAC
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jinling Hospital Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
Related publications
- The Eubacterium Rectale Derived Extracellular Vesicles Alleviate Cancer Cachexia Induced Lipolysis by Inhibiting Macrophage Polarization.J Extracell Vesicles · 2026 · PMID 42087590
This page is information, not medical advice. Discuss any trial with your doctor.